Karen Prange, SVP&Pres, Uro & Pelvic Health at BOSTON SCIENTIFIC CORP (BSX), sold 29,494 shares at $17.27 ($509K) on 2016-03-08, disclosed to the SEC on 2016-03-08.
Open-market sale of $509k BSX by SVP&Pres, Uro & Pelvic Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.27 | 14,747 | $255K | 50.0% |
| 2 | $17.27 | 14,747 | $255K | 50.0% |
| Total | $17.27 avg | 29,494 | $509K | 100% |
| Filing → |
| ATRC | SELL | 2025-03-07 | $465K | — | Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |